ValuentumAd

Official PayPal Seal













Fundamental data is updated weekly, as of the prior weekend. Please download the Full Report and Dividend Report for any changes.
Jul 13, 2018
What Are the Downside Risks of Gilead Sciences?
We think the risk-reward at Gilead remains positively skewed in investors’ favor, but let’s examine the downside case for Gilead Sciences so there are no surprises. It’s always a good approach to evaluate where an investor may go wrong with an investment idea, and assessing upside and downside cases, as in a fair value range, remains par for the course.
Jul 11, 2018
In the News: More Tariff Talk Keeps Markets Volatile
Many market observers were caught by surprise after President Trump continued down a path of escalating trade tensions late July 10.
Jul 11, 2018
What Are the Qualities of Highly-Rated Stocks on the Valuentum Buying Index?
Let’s walk through the seven most important considerations CEOs should focus on to score a high rating on the Valuentum Buying Index.
Jul 10, 2018
Twitter Working Backwards?
Image Source: Xiaobin LiuThe social media platform known for its tweets faced selling pressure after reports surfaced that it had removed 70 million fake accounts from its website. Social media is still a relatively young technology, and our top idea in the space remains the cash-rich Facebook.
Jul 5, 2018
In The News: Facebook, China and the Semiconductor Complex
Facebook gets a new Street high price target, while news ebbs and flows regarding US-China tech relations.
Jun 27, 2018
Roche Continues to Underwhelm
We like cutting-edge, novel therapies as they have a transformative impact on a small to mid-cap biotech as years of revenue growth could be in the cards. While new therapies are the life-blood of the research field, the impact of a new novel therapy on the growth prospects of a large cap is often muted, however. Such is the fate of Roche as it struggles to replace its mainstay oncology division with new patent-protected entities.
Jun 26, 2018
General Electric Stripping Businesses, Dividend in Aggregate
Image source: GE investor presentation. Once a seemingly unshakable component of the Dow Jones Industrial Average and one of the most-recognizable industrial firms in the world, General Electric announced further divestiture plans of its sprawling portfolio of businesses. More changes are in store for its dividend as well.
Jun 25, 2018
Still Expecting Strong 2018 from Digital Realty
Image Source: DLR Investor Presentation. In April of this year, we added Digital Realty Trust to the simulated Dividend Growth Newsletter portfolio. We think its addition adds a nice boost to the overall dividend yield to the portfolio.
Jun 24, 2018
Owens & Minor: Dividend At Risk, But Shares Not Expensive
We’re fans of consistent dividend payers with strong free-cash-flow coverage and solid balance sheets, but we remain very skeptical of companies with a dividend that seems “too good to be true” as the eye-popping dividend is often a byproduct of an egregious drop in the price of the stock. We believe Owens & Minor is an example of an overleveraged, slow-growth entity that may have trouble maintaining its dividend in coming years. We value shares at $20 each, however, so the market may be overreacting a bit on the downside.
Jun 20, 2018
Oracle’s Dividend Still Very Healthy
Image Source: May Wong. Oracle issued what is likely conservative fiscal first-quarter 2019 guidance, but the company continues to generate record amounts of operating cash flow and has a solid net cash position on the books. We’re not worried about the dividend.


The High Yield Dividend Newsletter, Best Ideas Newsletter, Dividend Growth Newsletter, Nelson Exclusive publication, and any reports, articles and content found on this website are for information purposes only and should not be considered a solicitation to buy or sell any security. The sources of the data used on this website are believed by Valuentum to be reliable, but the data’s accuracy, completeness or interpretation cannot be guaranteed. Valuentum is not responsible for any errors or omissions or for results obtained from the use of its newsletters, reports, commentary, or publications and accepts no liability for how readers may choose to utilize the content. Valuentum is not a money manager, is not a registered investment advisor and does not offer brokerage or investment banking services. Valuentum, its employees, and affiliates may have long, short or derivative positions in the stock or stocks mentioned on this site.